Novozymes' Partner Shengquan Invests $100 M for Cellulosic Ethanol Production Facility
- Jun 18, 2012
When China's Shengquan Group starts producing cellulosic ethanol next month, it will be the first in the world to do so on a commercial scale. More than that, the production will also be cost-competitive with conventional ethanol, as the feedstock is a waste product from Shengquan's current production.
Shengquan has invested $100 million in the new groundbreaking facility. Danish company Novozymes, one of the world leader in bioinnovation, will supply the enabling enzyme technology. The two companies first announced their plans in April this year and will sign the final agreement during Hu Jintao's visit to Denmark.
"When Shengquan opens its facility next month, it will be a milestone on the road away from the current oil-dependent economy toward a bioeconomy based on biological materials such as biomass and household and industrial waste," explains Steen Riisgaard, President and CEO of Novozymes.
Shengquan is one of the leading producer of furfural for resin production in the foundry industry. Furfural is produced from corncob xylose, with the cellulose from the corncob left behind as a waste product. Using Novozymes' enzymes, Shengquan will now be able to convert the cellulose into higher-value sugars that can be fermented to ethanol. Shengquan will market the ethanol as an industrial solvent.
"To continue to grow our country's economy while at the same time lessen our dependency on natural resources and minimizing the environmental impact, we need to start thinking of waste as a valuable resource," comments Yi Lin Tang, Chairman and President of Shengquan Group. "Basically, we want and need to nurture a green and circular bioeconomy which is less dependent on fossil resources."
Green Ambitions in China
The two companies signed the deal during Hu Jintao's visit to Denmark, in the presence of His Royal Highness Crown Prince Frederik of Denmark, Wang Qishan, Vice-Premier of the People's Republic of China, and Margrethe Vestager, Minister for Economic Affairs and the Interior, Denmark.
"As a company working in the clean tech space, we are thrilled by this important visit," adds Steen Riisgaard. "China leads the world when it comes to investments in green energy and biochemicals, and the country's long-term goals to improve its energy efficiency by 20% are among the most ambitious. This is a perfect match for Novozymes, because our biotechnology solutions make it possible to produce more with fewer resources and with less impact on the environment."
Made in Shandong
Shengquan Group is based in the city of Jinan in Shandong province, where Novozymes opened its new innovation and business center only last week. Novozymes is one of the largest Danish investors in China, with a total investment of more than $500 million since 1994. In 1997, Novozymes became the first company globally to initiate biotech R&D in China. Today, the company has four production facilities in China, more than 1,100 employees and plans to invest further in the country in the coming years.
In China, Novozymes has also entered into partnerships with companies including COFCO and Sinopec to develop advanced biofuels and with Dacheng to develop bioglycol. According to Bloomberg New Energy Finance, China could easily replace almost 40% of its annual gasoline consumption with advanced biofuels by 2030. This would cut CO2 emissions significantly and create almost 3 million jobs in rural areas. With a domestic engineering, construction and feedstock market worth $118 billion, Chinese players would be the major beneficiaries.
Novozymes is a biotech company with a strong focus on enzyme production. They are committed to changing the very foundations of their industrial system for the better by using industrial biotechnology. As a leading biotech company they believe that by using industrial biotechnology they can potentially re-engineer thousands of everyday products to deliver enhanced sustainability performance, at no extra cost. It is a compelling proposition, but one backed by strong evidence. They already market over 700 biotechnology products in 130 countries. The enzyme production leaves Novozymes with a global enzyme market share of 47% (2011).
Jinan Shengquan Group Co., Ltd., shortly named as SQ, established in 1979 and is located in Chemical Industrial Park Zhangqiu, Jinan. The factory is situated in an area of 1200 acres and their diverse and highly skilled workforce consists of approx 2000 employees. SQ holds the leading position of Chinese industry on various aspects viz. Production capacity, Technology, Product quality, Turnover, Profit & Tax, Management ability etc.
This document was provided by SpecialChem's editor. If you want to share your press
release, please send it to email@example.com.
SpecialChem reserves the right to refuse any article or news item.